A potential neuroimaging biomarker for depression in migraine patients: imbalance in excitation and inhibition in the medial superior frontal cortex
Journal of Psychiatry and Neuroscience · 2026
DOI: 10.1139/jpn-2026-0060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Psychiatry and Neuroscience, 2026. Verfasst von Xiaozheng Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China. Hauptthemen laut MEDLINE: Migraine Disorders, Depression, Frontal Lobe, Prefrontal Cortex. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Key Project of Medical Science Research of Hebei Province.
Themen: Depression
Abstract (Originalsprache)
Background
Depression is a common psychological and behavioural symptom experienced by people with migraines. However, the underlying neural mechanisms of depressive symptoms in this population are unclear.
Methods
In this study, we investigated the neural mechanisms underlying excitation–inhibition imbalance in patients with migraine accompanied by depressive symptoms (MD) using the Hurst exponent. We used Analysis of covariance to compare differences in the Hurst exponent between patients with MD, patients with migraine accompanied by non-depressive symptoms (MnD), and healthy controls (HC). Spearman's correlation analysis was used to calculate the correlation between the Hurst exponent of different brain regions and clinical variables.
Results
Compared with patients with migraine accompanied by MnD, patients with MD showed an increased Hurst exponent in the left lingual gyrus and medial superior frontal cortex. Compared with HC, MD showed an increased Hurst exponent in the right cerebellum crus 1 and right lingual gyrus. Compared with HC, MnD showed an increased Hurst exponent in the left cerebellum crus 2 and medial superior frontal cortex. The Hurst exponent of the medial superior frontal cortex in patients with migraine was significantly positively correlated with depression scores ( r = 0.3501, p = 0.0001).
Conclusions
Our study has identified imaging features of excitatory–inhibitory imbalance in MD. Imbalances in excitation and inhibition in the medial superior frontal cortex may serve as a promising candidate imaging marker for diagnosing and intervening in depressive symptoms in migraine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
- Department of Neurology, the Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China.
- Department of Neurology of the Hebei General Hospital, Shijiazhuang, Hebei 050050, China.
ORCID-Profile: Xiaozheng Liu
Förderung
- Key Project of Medical Science Research of Hebei Province
Zitieren
APA
Liu, X., Fu, F., Cao, Y., Chen, K., Cheng, J., & Li, Y. (2026). A potential neuroimaging biomarker for depression in migraine patients: imbalance in excitation and inhibition in the medial superior frontal cortex. Journal of Psychiatry and Neuroscience. https://doi.org/10.1139/jpn-2026-0060
Vancouver
Liu X, Fu F, Cao Y, Chen K, Cheng J, Li Y. A potential neuroimaging biomarker for depression in migraine patients: imbalance in excitation and inhibition in the medial superior frontal cortex. Journal of Psychiatry and Neuroscience. 2026. doi:10.1139/jpn-2026-0060
BibTeX
@article{Liu2026,
author = {Liu, Xiaozheng and Fu, Fangwang and Cao, Yungang and Chen, Keyang and Cheng, Jinming and Li, Yan},
title = {A potential neuroimaging biomarker for depression in migraine patients: imbalance in excitation and inhibition in the medial superior frontal cortex},
journal = {Journal of Psychiatry and Neuroscience},
year = {2026},
doi = {10.1139/jpn-2026-0060}
}
EUVIMED